(19)
(11) EP 2 582 727 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.04.2017 Bulletin 2017/16

(45) Mention of the grant of the patent:
19.10.2016 Bulletin 2016/42

(21) Application number: 11796394.2

(22) Date of filing: 15.06.2011
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
C07K 16/30(2006.01)
 C07K 16/18(2006.01)
G01N 33/574(2006.01)
(86) International application number:
PCT/US2011/040580
(87) International publication number:
WO 2011/159835 (22.12.2011 Gazette 2011/51)

(54)

ANTIBODIES TO ENDOPLASMIN AND THEIR USE

ANTIKÖRPER ZU ENDOPLASMIN UND DEREN VERWENDUNG

ANTICORPS DIRIGÉS CONTRE L'ENDOPLASMINE ET LEUR UTILISATION

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 16.06.2010 US 355516 P

(43) Date of publication of application:
24.04.2013 Bulletin 2013/17

(60) Divisional application:
16187573.7 / 3135692

(73) Proprietor: University of Pittsburgh- Of the Commonwealth System of Higher Education
Pittsburgh, PA 15260 (US)

(72) Inventors:
  • FERRONE, Soldano
    Pittsburgh, PA 15217 (US)
  • WANG, Xinhui
    Pittsburgh, PA 15238 (US)
  • CONRADS, Thomas, P.
    Reston, VA 20191 (US)
  • FAVOINO, Elvira
    I-70010 Casamassima Ba (IT)
  • HOOD, Brian
    Reston, VA 20191 (US)

(74) Representative: Gowshall, Jonathan Vallance 
Forresters Skygarden Erika-Mann-Strasse 11
80636 München
80636 München (DE)


(56) References cited: : 
WO-A1-2004/087205
WO-A1-2012/075324
US-A1- 2004 001 789
 WO-A1-2009/113074
WO-A2-2006/120230
   
  • ARNOLD-SCHILD D. ET AL.: 'One-Step Single-Chain Fv Recombinant Antibody- based Purification of gp96 for Vaccine Development' CANCER RESEARCH vol. 60, 01 August 2000, pages 4175 - 4178, XP002175252
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).